Clinical trial Recruiting at 1 site Observational Ages 18 and up

ICG fluorescence imaging to show bone blood flow in open fractures and infections

Official title: Prospective Observational Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients: Early Comparison With a Novel Imaging Device

Run by Dartmouth-Hitchcock Medical Center · NCT06793644 · Data updated 2026-11-12

This will test whether a dye-based fluorescence camera can show bone blood flow in adults with open fractures or bone infections so surgeons can choose the best treatment.

More Trauma Injury trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorDartmouth-Hitchcock Medical Center
Academic / other
Locations1 site (Lebanon, New Hampshire)
StatusRecruiting
StartedJune 10, 2025
Main results expectedOctober 2026
Study endsOctober 2027
Registry record updatedMarch 19, 2026
Trial IDNCT06793644 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with open extremity fractures or fracture-related bone infections who are scheduled for surgical fixation, fusion, or debridement and can give informed consent are ideal candidates.

Probably not a fit

Patients with hand fractures, iodine allergy, burns at the fracture site, or those unable to provide consent — as well as patients not undergoing planned surgical care at the site — are unlikely to benefit from this imaging approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses indocyanine green (ICG) fluorescence imaging (cBPI system) during planned surgical care to visualize bone perfusion in adults with open extremity fractures or fracture-related infections. Participants 18 and older who are undergoing external or internal fixation, joint fusion, or debridement will receive the imaging during their routine operative procedures without changing standard treatment. Patients with hand fractures, iodine allergy, or burns at the fracture site are excluded. The goal is to correlate the imaging findings with bone health and healing potential to inform future surgical decision-making.

Why it matters

Potential benefit: If successful, surgeons could use real-time images of bone blood flow to pick treatments that lower complication risk and improve healing.

How similar studies have gone: ICG fluorescence is well established for soft-tissue perfusion imaging, but its application to bone blood flow is relatively novel and supported mainly by limited pilot and feasibility data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients 18 years of age or older.
* Open extremity fracture, planning for management with external fixation, internal fixation or joint fusion.
* Fracture Related Infection, planning for management with debridement and possible removal of hardware.
* Will have all planned fracture care surgeries performed by a participating surgeon or delegate.
* Provision of informed consent.

Exclusion Criteria:

* Inability of patient to provide informed consent
* Fracture of the hand.
* Iodine allergy.
* Burns at the fracture site.

Where it's running

  • Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.